Association Between the (GT)n Polymorphism of the HO-1 Gene Promoter Region and Cancer Risk: a Meta-analysis |
Zhang, Ling
(Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education)
Song, Fang-Fang (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education) Huang, Yu-Bei (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education) Zheng, Hong (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education) Song, Feng-Ju (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education) Chen, Ke-Xin (Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education) |
1 | Aruoma OI, Grootveld M, Bahorun T (2006). Free radicals in biology and medicine: from inflammation to bioteclmology. Biofactors, 27, 1-3. DOI |
2 | Berberat PO, Dambrauskas Z, Gulbinas A, et al (2005). Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res, 11, 3790-8. DOI ScienceOn |
3 | Chang KW, Lee TC, Yeh WI, et al (2004). Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer, 91, 1551-5. DOI |
4 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7 , 177-88. DOI ScienceOn |
5 | Chian S, Li YY, Wang XJ, et al (2014). Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the nrf2 pathway. Asian Pac J Cancer Prev, 15, 2911-6. 과학기술학회마을 DOI ScienceOn |
6 | Datta D, Banerjee P, Gasser M, Waaga-Gasser AM, Pal S (2010). CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1. J BioI Chem, 285, 36842-8. DOI |
7 | Davies KJ (1995). Oxidative stress: the paradox of aerobic life. Biochem Soc Symp, 61, 1-31. |
8 | Deshane J, Wright M, Agarwal A (2005). Heme oxygenase-1 expression in disease states. Acta Biochim Pol, 52, 273-84. |
9 | Egger M, Davey Smith G, Sclmeider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI ScienceOn |
10 | Exner M, Minar E, Wagner 0, Schillinger M (2004). The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med, 37, 1097-104. DOI |
11 | Hu JL, Li ZY, Liu W, et al (2010). Polymorphism in heme oxygenase-l (HO-1) promoter and alcohol are related to the risk of esophageal squamous cell carcinoma on Chinese males. Neoplasma, 57, 86-92. DOI |
12 | Higgins JPT, Green S, eds (2009). Cochrane Handoook for Systematic Reviews of Interventions, Version 5.0.2 [Updated September 2009]. The Cochrane Collaooration, Oxford. |
13 | Hong CC, Ambrosone CB, Ahn J, et al (2007). Genetic variability in iron-related oxidative stress pathways (Nrf2, NQO1, NOS3, and HO-1), ironintake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev , 16, 1784-94. DOI ScienceOn |
14 | Kikuchi A, Yamaya M, Suzuki S, et al (2005). Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-l gene promoter polymorphism. Hum Genet, 116, 354-60. DOI |
15 | Jiraskova A, Novotny J, Novotny L, et al (2012). Association of serum bilirubin and promoter variations in HMOX1and UGT1A1 genes with sporadic colorectal cancer. Int J Cancer, 131, 1549-55. DOI |
16 | Jozkowicz A, Was H, Dulak J (2007). Heme oxygenase-1 in tumors: Is it a false friend? Antioxid Redox Signal, 9, 2099-117. DOI |
17 | Kimpara T, TakedaA, Watanabe K, et al (1997). Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet, 100, 145-7. DOI ScienceOn |
18 | Li Q, Wang JM, Peng Y, et al (2013). Association of DNA base-excision repair XRCC1 , OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population. Asian Pac J Cancer Prev, 14, 5145-51. 과학기술학회마을 DOI ScienceOn |
19 | Lin SC, Liu CJ, Yeh WI, et al (2006). Functional polymorphism in NFKBl promoter is related to the risks of oral squamous cell carcinoma occuning on older male areca (betel) chewers. Cancer Lett, 243, 47-54. DOI ScienceOn |
20 | Li Y, Ambrosone CB, McCullough MJ, et al (2009). Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis, 30, 777-84. DOI ScienceOn |
21 | Lo SS, Lin SC, Wu CW, et al (2007). Heme Oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion. Ann Surg Oncol, 14, 2250-6. DOI |
22 | Luo H, Li Z, Qing Y, et al (2014). Single nucleotide polymorphisms of DNA base-excision repair genes (APEl, OGG1 and XRCC1) associated with breast cancer risk in a Chinese population. Asian Pac J Cancer Prev, 15, 1133-40. 과학기술학회마을 DOI ScienceOn |
23 | Murakami A, Fujimori Y, Yoshikawa Y, et al (2012). Heme Oxygenase-1promoter polymorphism is associated with risk of malignant mesothelioma. Lung, 190, 333-7. DOI |
24 | Maines MD (1997). The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol, 37,517-54. DOI ScienceOn |
25 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
26 | Marcos M, Gomez-Munuera M, Pastor I, Gonzalez-Sanniento R, Laso FJ (2009). Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis. Am J Epidemiol, 170, 948-56. DOI |
27 | Song F, Li X, Zhang M, et al (2009). Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes in a Chinese population. Am J Epidemiol, 170, 747-56. DOI |
28 | Nulm P, Kunzli BM, Hennig R, et al (2009). Heme oxygenase-1 and its metaoolites affect pancreatic tumor growth in vivo. Mol Cancer, 8, 37 DOI |
29 | Okamoto I, Krogler J, Endler G, et al (2006). A microsatellite polymorphism in the heme oxygenase-l gene promoteris associated withriskfor melanoma. Int J Cancer, 119, 1312-5. DOI |
30 | Sawa T, Mounawar M, Tatemichi M, et al (2008). Increased risk of gastric cancer in Japanese subjects is associated with microsatellite polymorphisms in the heme oxygenase-l and the inducible nitric oxide synthase gene promoters. Cancer Lell, 269, 78-84. DOI |
31 | Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008-12. DOI ScienceOn |
32 | Vashist YK, Uzunoglu G, Cataldegirmen G, et al (2009). Haeme oxygenase-1 promoter polymorphism is an independent prognostic marker of gastrointestinal stromal tumour. Histopathology, 54, 303-8. DOI ScienceOn |
33 | Vashist YK, Uzungolu G, Kutup A, et al (2011). Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer. J Surg Oncol, 104, 305-11 DOI |
34 | Woolf B (1955). On estimating the relation between blcxxl group and disease. Ann Hum Genet, 19,251-3. DOI ScienceOn |
35 | Sacca P, Meiss R, Casas G, et al (2007). Nuclear translocation of haeme oxygenase-l is associated to prostate cancer. Br J Cancer, 97, 1683-9. DOI |
36 | Yamada N, Yamaya M, Okinaga S, et al (2000). Microsatellite polymorphism in the heme oxygenase-l gene promoter is associated with susceptibility to emphysema. Am J Hum Genet, 66, 187-95. DOI ScienceOn |
37 | Hirai H, Kubo H, Yamaya M, et al (2003). Microsatellite polymorphism in heme oxygenase-l gene promoter is associated with susceptibility to oxidant-induced apoptosis inlymphoblastoid cell lines. Blood, 102, 1619-24. DOI |